Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66072-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#66072-1-Ig, RRID:AB_11042325
- Product name
- CPT1C antibody
- Antibody type
- Monoclonal
- Description
- CPT1C antibody (Cat. #66072-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, pig and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 5D11B5
- Vial size
- 20ul, 150ul
Submitted references APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition.
Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer.
CPT1C-mediated fatty acid oxidation facilitates colorectal cancer cell proliferation and metastasis.
MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation.
Polyphyllin I improves myocardial damage in coronary artery disease via modulating lipid metabolism and myocardial apoptosis.
Differential regulatory roles of microRNAs during intramuscular adipogenesis in Chinese Guizhou Congjiang Xiang pigs.
Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression.
Zhao H, Cheng X, Yan L, Mi F, Wang W, Hu Y, Liu X, Fan Y, Min Q, Wang Y, Zhang W, Wu Q, Zhan Q
Cell communication and signaling : CCS 2024 May 23;22(1):283
Cell communication and signaling : CCS 2024 May 23;22(1):283
Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer.
Muley H, Valencia K, Casas J, Moreno B, Botella L, Lecanda F, Fadó R, Casals N
International journal of molecular sciences 2023 Jan 4;24(2)
International journal of molecular sciences 2023 Jan 4;24(2)
CPT1C-mediated fatty acid oxidation facilitates colorectal cancer cell proliferation and metastasis.
Li J, Zheng W, Wu J, Zhang J, Lv B, Li W, Liu J, Zhang X, Huang T, Luo Z
Acta biochimica et biophysica Sinica 2023 Apr 20;55(8):1301-1309
Acta biochimica et biophysica Sinica 2023 Apr 20;55(8):1301-1309
MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation.
Zhang T, Zhang Y, Liu J, Ma Y, Ye Q, Yan X, Ding L
Cancer & metabolism 2022 Jan 20;10(1):2
Cancer & metabolism 2022 Jan 20;10(1):2
Polyphyllin I improves myocardial damage in coronary artery disease via modulating lipid metabolism and myocardial apoptosis.
Yang Z, Yang X, An M
Journal of biochemical and molecular toxicology 2022 Dec;36(12):e23219
Journal of biochemical and molecular toxicology 2022 Dec;36(12):e23219
Differential regulatory roles of microRNAs during intramuscular adipogenesis in Chinese Guizhou Congjiang Xiang pigs.
Tan L, Chen Z, Ruan Y, Xu H
Epigenetics 2022 Dec;17(12):1800-1819
Epigenetics 2022 Dec;17(12):1800-1819
Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
Wu T, Luo G, Lian Q, Sui C, Tang J, Zhu Y, Zheng B, Li Z, Zhang Y, Zhang Y, Bao J, Hu J, Shen S, Yang Z, Wu J, Wang K, Zhao Y, Yang S, Wang S, Qiu X, Wang W, Wu X, Wang H, Gu J, Chen L
Hepatology (Baltimore, Md.) 2021 Dec;74(6):3249-3268
Hepatology (Baltimore, Md.) 2021 Dec;74(6):3249-3268
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression.
Chen T, Wu G, Hu H, Wu C
Journal of gastrointestinal oncology 2020 Aug;11(4):695-707
Journal of gastrointestinal oncology 2020 Aug;11(4):695-707
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 66072-1-Ig(CPT1C antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human testis using 66072-1-Ig(CPT1C antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CPT1C antibody from Proteintech is a mouse monoclonal antibody to a fusion protein of human CPT1C. This antibody recognizes human antigen. The CPT1C antibody has been validated for the following applications: ELISA, WB, IHC analysis.
